Sara E. Bellomo
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 9
- Colorectal Cancer Treatments and Studies 4
- Cancer Cells and Metastasis 3
- PARP inhibition in cancer therapy 2
-
- Cancer Genomics and Diagnostics 5
- Co-authors
- Enzo Médico (7 shared papers)Andrea Bertotti (5 shared papers)Livio Trusolino (4 shared papers)Claudio Isella (6 shared papers)Consalvo Petti (4 shared papers)Rebecca Senetta (2 shared papers)Alfredo Mellano (3 shared papers)Mark De Ridder (2 shared papers)
In The Last Decade
Sara E. Bellomo
18 papers receiving 822 citations
Sara E. Bellomo's Hit Papers
Peers
Comparison fields: 5 of 56
- Cancer Research 262
- Oncology 431
- Pathology and Forensic Medicine 156
- Biotechnology 36
- Molecular Biology 246
Countries citing papers authored by Sara E. Bellomo
This map shows the geographic impact of Sara E. Bellomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Bellomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Bellomo more than expected).
Fields of papers citing papers by Sara E. Bellomo
This network shows the impact of papers produced by Sara E. Bellomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Bellomo. The network helps show where Sara E. Bellomo may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara E. Bellomo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stromal contribution to the colorectal cancer transcriptome Hit paper breakdown → | 2015 | 458 |
| 2 | 2017 | 186 | |
| 3 | 2020 | 51 | |
| 4 | 2022 | 31 | |
| 5 | 2017 | 20 | |
| 6 | 2024 | 18 | |
| 7 | 2022 | 18 | |
| 8 | 2023 | 16 | |
| 9 | 2020 | 12 | |
| 10 | 2020 | 8 | |
| 11 | 2023 | 5 | |
| 12 | 2016 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2024 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2023 | 0 |
About Sara E. Bellomo
Sara E. Bellomo is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Immunology, having authored 21 papers that have together received 833 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Cells and Metastasis (3 papers), Molecular Biology Techniques and Applications (2 papers), PARP inhibition in cancer therapy (2 papers), Acute Myeloid Leukemia Research (1 paper) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Cancer Research (262 citations), Oncology (431 citations), Pathology and Forensic Medicine (156 citations), Biotechnology (36 citations) and Molecular Biology (246 citations). Sara E. Bellomo has collaborated with scholars based in Italy, Belarus and Belgium. Frequent co-authors include Enzo Médico, Andrea Bertotti, Livio Trusolino, Claudio Isella, Consalvo Petti, Rebecca Senetta, Alfredo Mellano, Mark De Ridder, Andrea Muratore and Guy Storme. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Cancers, Nature Communications and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.